Charles River Laboratories International, Inc. (CRL) vs Walgreens Boots Alliance, Inc. (WBA)

A side-by-side comparison of Charles River Laboratories International, Inc. and Walgreens Boots Alliance, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnCRL vs WBA

growth of $100 · dividends reinvested · last 25y
CRL +635.6%WBA -26.8%CRL compounded faster
Log scale — wide-divergence pair
101001k10kStart $10020052010201520202025$736$73
CRL WBA

CRL vs WBA: by the numbers

  • CRL is the larger company ($11.58B vs $10.37B market cap).
  • Both run net losses; WBA's is the smaller (-4.07% vs -4.59% net margin).
  • CRL grew revenue faster over the past five years (5.77% vs 3.53% CAGR).

Metrics side by side

Valuation

MetricCRLWBA
Forward P/E20.207.65
P/S ratio2.730.07
P/B ratio3.731.44
EV / EBITDA16.80N/A
FCF yield3.56%5.60%

Profitability

MetricCRLWBA
Gross margin31.86%17.13%
Operating margin11.77%-2.02%
Net margin-4.59%-4.07%
ROE-6.28%-87.68%
ROIC8.36%-24.28%

Growth (annualized)

MetricCRLWBA
Revenue CAGR (5Y)5.77%3.53%
EPS CAGR (5Y)-40.99%N/A
FCF CAGR (5Y)6.43%-33.20%
Total return CAGR (5Y)-9.80%-16.99%

Frequently asked

Which has grown faster, CRL or WBA?
Over the past five years, CRL grew revenue faster — CRL at a 5.77% CAGR versus WBA at 3.53%.
How have CRL and WBA total returns compared?
Over the past 10 years, CRL delivered 10.55% and WBA delivered -14.92% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.